We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Thousands of Copy Number Variations Cataloged in New Genomic Database

By LabMedica International staff writers
Posted on 30 Jul 2009
A valuable new genomic database has been placed on the Internet, where it is freely available to gene researchers around the world.

The database, which catalogs and characterizes 54,462 individual DNA copy number variations (CNVs), was assembled by investigators at The Children's Hospital of Philadelphia (PA, USA). More...
They analyzed blood samples taken from 2,026 disease-free individuals, using high-density, SNP-based oligonucleotide microarrays. The population studied was comprised mainly of Caucasians (65.2%) and African-Americans (34.2%). The samples were analyzed for CNVs in a single study using a uniform array platform and computational process.

Analysis of the data collected revealed that 77.8% of CNVs were from multiple unrelated individuals. These nonunique CNVs mapped to 3,272 distinct regions of genomic variation spanning 5.9% of the genome; 51.5% of these were previously unreported, and more than 85% were rare. On average the subjects in the study had approximately 27 CNVs each.

Results of the study were published in the July 10, 2009, online edition of the journal Genome Research, and the entire database was posted to The Children's Hospital of Philadelphia's website, where it is freely available in searchable form to gene researchers worldwide.

"This resource will be very important in enabling rapid and accurate diagnoses of rare diseases resulting from CNVs,” said first author Dr. Tamim H. Shaikh, assistant professor of pediatrics at The Children's Hospital of Philadelphia. "In order to pinpoint the one CNV that is the cause of a disease, it is critical to quickly eliminate those that are part of the spectrum of normal variation that exists in the human genome. That's what this CNV data and other similar resources allow us to do.”

Related Links:
The Children's Hospital of Philadelphia



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings support integrating high-performing plasma p-tau217 assays into Alzheimer’s diagnostic workflows, provided that platform-specific calibration and standardized testing protocols are in place. (Image Credit: Adobe Stock)

Head-to-Head Study Compares Blood Tests for Early Alzheimer’s Disease Detection

Accurate, scalable diagnostics are becoming increasingly important as disease-modifying therapies reshape Alzheimer’s disease care, yet many patients still rely on invasive cerebrospinal fluid sampling... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.